Avicena LVDP Validation Study
NCT05633004 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 406
Last updated 2022-12-01
Summary
The purpose of the study is to determine the relationship between non-invasive measurement of left ventricular diastolic pressure (LVDP) using the Vivio System, compared with invasively measured LVDP via direct measurement during left heart catheterization.
Conditions
Interventions
- DEVICE
-
Vivio
Non-invasive estimation of Left-Ventricular End Diastolic Pressure (LVEDP)
Sponsors & Collaborators
-
Avicena LLC
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-27
- Primary Completion
- 2022-09-08
- Completion
- 2022-09-30
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Impact of Cardiac Resynchronization Therapy on Right Ventricular Function in Left Ventricular Assist Device Patients
NCT02169076 ·Status: WITHDRAWN ·Phase: NA
-
Does Lung Impedance Correlate With Changes in BNP in Stable and Acutely Decompensated Heart Failure Patients?
NCT00560339 ·Status: UNKNOWN
-
Integrated Diagnostics Driven Diuretic and Chronic Medication Management for Heart Failure
NCT02698241 ·Status: TERMINATED ·Phase: NA
-
Intrathoracic Bloodvolume Measurement by Contrast Enhanced Ultrasound: Validation of the Technique and Evaluation as a Measurement of Response to Cardiac Resynchronization Therapy: a Pilot Study
NCT01735838 ·Status: COMPLETED
-
LV Only MPP With SyncAV
NCT03567096 ·Status: COMPLETED ·Phase: NA
-
REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT)
NCT05652218 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Biventricular Versus Right Ventricular Pacing
NCT06298669 ·Status: TERMINATED ·Phase: NA
-
Changes in Doppler Signals From the Lung Due to Cardiac Resynchronization in Heart Failure Patients
NCT02179203 ·Status: COMPLETED
-
Evaluation of Left Ventricular (LV) Lead Positioning Using MediGuide
NCT01917266 ·Status: COMPLETED
-
Effect of Cardiac Resynchronization Therapy (CRT) on Left Ventricular Assist Device (LVAD) Function
NCT04153786 ·Status: TERMINATED ·Phase: NA
-
Impact of Ventricular Pacing in Unselected ICD/CRT-D Patients
NCT01169896 ·Status: COMPLETED
-
REGISTRY EVALUATION OF VITAL INFORMATION FOR VADs IN AMBULATORY LIFE
NCT01369407 ·Status: COMPLETED
-
Adaptive Cardiac Resynchronization Therapy in Patients With RBBB
NCT05936294 ·Status: TERMINATED ·Phase: NA
-
Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD
NCT03836482 ·Status: RECRUITING ·Phase: NA
-
Clinical Usefulness and Efficacy of Intrathoracic Impedance Monitoring Using the OptiVol Patient Alert(TM)
NCT00488501 ·Status: COMPLETED
-
A Multi-site, Pre-clinical, Prospective Data Collection Study in Patients Undergoing a Right Heart Catheterization
NCT07010562 ·Status: NOT_YET_RECRUITING
-
Non-Invasive Method for Evaluation of Cardiac Resynchronization Therapy
NCT05868616 ·Status: RECRUITING
-
LVAD Conditioning for Cardiac Recovery
NCT03238690 ·Status: RECRUITING ·Phase: NA
-
VIVO™ Accuracy Study
NCT03340142 ·Status: COMPLETED ·Phase: NA
-
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
NCT06310031 ·Status: RECRUITING ·Phase: NA
-
Correlating QLV Interval to Left Ventricular (LV) Lead Position in Patients Receiving Cardiac Resynchronization Therapy.
NCT02166762 ·Status: COMPLETED ·Phase: NA
-
Acute Feedback on Left ventrIcular Lead Implantation Location for Cardiac Resynchronization Therapy
NCT01996397 ·Status: COMPLETED ·Phase: NA
-
Comparison Study of BNP and Thoracic Impedance Measurements on Arrhythmias
NCT00580255 ·Status: WITHDRAWN
-
Response of Cardiac Resynchronization Therapy Optimization With Ventricle to Ventricle Timing in Heart Failure Patients
NCT00187200 ·Status: COMPLETED ·Phase: PHASE4
-
Resynchronization for Ambulatory Heart Failure Trial - LV Endocardial
NCT02757976 ·Status: TERMINATED ·Phase: NA